Evidence map›Paper›PMID 33006196›Full record

ArticleThe FEBS journal2021

Genome-wide postnatal changes in immunity following fetal inflammatory response.

Daniel Costa, Núria Bonet, Amanda Solé, José Manuel González de Aledo-Castillo, Eduard Sabidó, Ferran Casals, Carlota Rovira, Alfons Nadal, Jose Luis Marin, Teresa Cobo and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The FEBS journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Daniel CostaDepartment of Pediatrics, Hospital de Figueres, Spain.ORCID 0000-0002-5284-557X
Núria BonetGenomics Core Facility, Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.ORCID 0000-0003-0574-2575
Amanda SoléDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.ORCID 0000-0002-8985-9481
José Manuel González de Aledo-CastilloInborn Errors of Metabolism Section, Laboratory of Biochemistry and Molecular Genetics, Hospital Clínic, Barcelona, Spain.ORCID 0000-0002-7622-417X
Eduard SabidóDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.ORCID 0000-0001-6506-7714
Ferran CasalsGenomics Core Facility, Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.ORCID 0000-0002-8941-0369
Carlota RoviraHospital Sant Joan de Déu, Barcelona, Spain.ORCID 0000-0002-0174-674X
Alfons NadalDepartment of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain.ORCID 0000-0002-5366-093X
Jose Luis MarinHospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centre for Biomedical Research on Rare Diseases (CIBER-ER), University of Barcelona, Spain.ORCID 0000-0003-3953-4272
Teresa CoboHospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centre for Biomedical Research on Rare Diseases (CIBER-ER), University of Barcelona, Spain.ORCID 0000-0003-3130-1829
Robert CasteloDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.ORCID 0000-0003-2229-4508
Universitat Pompeu Fabra · ESCentre for Biomedical Network Research on Rare Diseases · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínic de Barcelona · ESHospital Sant Joan de Déu Barcelona · ES

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca SGR17-1020Agència de Gestió d'Ajuts Universitaris i de Recerca SGR17-595Instituto de Salud Carlos III PT17/0009/0014Instituto de Salud Carlos III PT17/0019Ministerio de Economía y Competitividad CEX2018-000792-MMinisterio de Economía y Competitividad SEV-2012-0208Ministerio de Economía y Competitividad TIN2015-71079-P
6 · The paper itself

Abstract

The fetal inflammatory response (FIR) increases the risk of perinatal brain injury, particularly in extremely low gestational age newborns (ELGANs, < 28 weeks of gestation). One of the mechanisms contributing to such a risk is a postnatal intermittent or sustained systemic inflammation (ISSI) following FIR. The link between prenatal and postnatal systemic inflammation is supported by the presence of well-established inflammatory biomarkers in the umbilical cord and peripheral blood. However, the extent of molecular changes contributing to this association is unknown. Using RNA sequencing and mass spectrometry proteomics, we profiled the transcriptome and proteome of archived neonatal dried blood spot (DBS) specimens from 21 ELGANs. Comparing FIR-affected and unaffected ELGANs, we identified 782 gene and 27 protein expression changes of 50% magnitude or more, and an experiment-wide significance level below 5% false discovery rate. These expression changes confirm the robust postnatal activation of the innate immune system in FIR-affected ELGANs and reveal for the first time an impairment of their adaptive immunity. In turn, the altered pathways provide clues about the molecular mechanisms triggering ISSI after FIR, and the onset of perinatal brain injury. DATABASES: EGAS00001003635 (EGA); PXD011626 (PRIDE).

Indexed as

BiomarkersDried Blood Spot TestingFemaleFetusGene Expression RegulationGenome, HumanGestational AgeHumansImmune SystemInfant, NewbornInflammationMass SpectrometryPregnancyProteomeSequence Analysis, RNATranscriptomeBiomarkersProteomefetal inflammatory responsepostnatal immunitypreterm birthproteomicstranscriptomics

Identifiers

PMID33006196
PMCPMC8049052
OpenAlexW3091157818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.